Heart Rate Recovery as a Predictor of Long-Term Adverse Events after Negative Exercise Testing in Patients with Chest Pain and Pre-Test Probability of Coronary Artery Disease from 15% to 65.
chest pain
heart rate recovery
negative exercise testing
predictors
prognosis
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
30 Jun 2023
30 Jun 2023
Historique:
received:
17
05
2023
revised:
15
06
2023
accepted:
27
06
2023
medline:
14
7
2023
pubmed:
14
7
2023
entrez:
14
7
2023
Statut:
epublish
Résumé
The prognosis of patients with chest pain after a negative exercise test is good, but some adverse events occur in this low-risk group. The aim of our study was to identify predictors of long-term adverse events after a negative exercise test in patients with chest pain and a lower intermediate (15-65%) pre-test probability of coronary artery disease (CAD) and to assess the prognostic value of exercise electrocardiography and exercise stress echocardiography in this group of patients. We identified from our stress test laboratory database 862 patients with chest pain without previously known CAD and with a pre-test probability of CAD ranging from 15 to 65% (mean 41 ± 14%) who underwent exercise testing. Patients were followed for the occurrence of death, non-fatal myocardial infarction (MI) and clinically guided revascularization. During the median follow-up of 94 months, 87 patients (10.1%) had an adverse event (AE). A total of 30 patients died (3.5%), 23 patients suffered non-fatal MI (2.7%) and 34 patients (3.9%) had clinically guided revascularization (20 patients percutaneous and 14 patients surgical revascularizations). Male gender, age, the presence of diabetes and a slow heart rate recovery (HRR) in the first minute after exercise were independently related to the occurrence of AEs. Adverse events occurred in 10.3% of patients who were tested by exercise stress echocardiography and in 10.0% of those who underwent stress electrocardiography ( The risk of AEs after negative exercise testing in patients with a pre-test probability of CAD of 15-65% is low. Male patients with a history of diabetes and slow HRR in the first minute after exercise have an increased risk of an adverse outcome.
Sections du résumé
BACKGROUND
BACKGROUND
The prognosis of patients with chest pain after a negative exercise test is good, but some adverse events occur in this low-risk group. The aim of our study was to identify predictors of long-term adverse events after a negative exercise test in patients with chest pain and a lower intermediate (15-65%) pre-test probability of coronary artery disease (CAD) and to assess the prognostic value of exercise electrocardiography and exercise stress echocardiography in this group of patients.
METHODS
METHODS
We identified from our stress test laboratory database 862 patients with chest pain without previously known CAD and with a pre-test probability of CAD ranging from 15 to 65% (mean 41 ± 14%) who underwent exercise testing. Patients were followed for the occurrence of death, non-fatal myocardial infarction (MI) and clinically guided revascularization.
RESULTS
RESULTS
During the median follow-up of 94 months, 87 patients (10.1%) had an adverse event (AE). A total of 30 patients died (3.5%), 23 patients suffered non-fatal MI (2.7%) and 34 patients (3.9%) had clinically guided revascularization (20 patients percutaneous and 14 patients surgical revascularizations). Male gender, age, the presence of diabetes and a slow heart rate recovery (HRR) in the first minute after exercise were independently related to the occurrence of AEs. Adverse events occurred in 10.3% of patients who were tested by exercise stress echocardiography and in 10.0% of those who underwent stress electrocardiography (
CONCLUSION
CONCLUSIONS
The risk of AEs after negative exercise testing in patients with a pre-test probability of CAD of 15-65% is low. Male patients with a history of diabetes and slow HRR in the first minute after exercise have an increased risk of an adverse outcome.
Identifiants
pubmed: 37443623
pii: diagnostics13132229
doi: 10.3390/diagnostics13132229
pmc: PMC10341283
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Trends Cardiovasc Med. 2022 Oct;32(7):448-453
pubmed: 34384879
Am J Cardiol. 2004 Jan 1;93(1):10-3
pubmed: 14697458
J Am Heart Assoc. 2017 May 9;6(5):
pubmed: 28487388
Am Heart J. 2012 Mar;163(3):454-61
pubmed: 22424017
Circ Cardiovasc Qual Outcomes. 2017 Dec;10(12):
pubmed: 29217675
Circulation. 2001 May 29;103(21):2566-71
pubmed: 11382725
Ann Med. 2017 Aug;49(5):404-410
pubmed: 28166422
Ann Intern Med. 2000 Apr 4;132(7):552-5
pubmed: 10744592
Clin Physiol Funct Imaging. 2014 Sep;34(5):327-39
pubmed: 24237859
Circ Cardiovasc Imaging. 2019 Jun;12(6):e008564
pubmed: 31167561
Am J Cardiol. 2002 Oct 15;90(8):848-52
pubmed: 12372572
Eur Heart J Cardiovasc Imaging. 2017 Sep 01;18(9):980-987
pubmed: 28329376
Circulation. 2011 Sep 13;124(11):1239-49
pubmed: 21844080
J Am Coll Cardiol. 1998 Nov;32(5):1280-6
pubmed: 9809937
Can J Cardiol. 2012 Mar-Apr;28(2):201-7
pubmed: 22336522
J Am Coll Cardiol. 2021 Sep 21;78(12):1257-1265
pubmed: 34531027
Circ Cardiovasc Interv. 2022 May;15(5):e011728
pubmed: 35485232
Eur Heart J. 2011 Jun;32(11):1316-30
pubmed: 21367834
Int J Cardiol. 2022 Oct 15;365:19-29
pubmed: 35901907
Circulation. 2001 Oct 16;104(16):1911-6
pubmed: 11602493
Circ Cardiovasc Imaging. 2015 May;8(5):
pubmed: 25904573
J Auton Nerv Syst. 2000 May 12;80(3):169-74
pubmed: 10785283
J Am Coll Cardiol. 1999 Sep;34(3):618-20
pubmed: 10483939
Am J Cardiol. 2015 Apr 15;115(8):1049-55
pubmed: 25728643
J Am Soc Echocardiogr. 2005 Dec;18(12):1440-63
pubmed: 16376782
Cardiovasc Ultrasound. 2008 May 29;6:21
pubmed: 18510723
Circulation. 1998 Feb 17;97(6):535-43
pubmed: 9494023
Cardiovasc Ultrasound. 2017 Jan 18;15(1):3
pubmed: 28100277
J Am Soc Echocardiogr. 2007 Mar;20(3):244-52
pubmed: 17336749
Circulation. 2015 Mar 10;131(10):861-70
pubmed: 25587100
Am J Med. 2001 Jul;111(1):18-23
pubmed: 11448656
J Am Coll Cardiol. 2007 Jan 16;49(2):227-37
pubmed: 17222734
N Engl J Med. 1999 Oct 28;341(18):1351-7
pubmed: 10536127
Vasc Health Risk Manag. 2005;1(1):85-9
pubmed: 17319101
Eur Heart J. 2016 Oct 14;37(39):2999-3058
pubmed: 27567407
Circulation. 2001 Apr 24;103(16):2072-7
pubmed: 11319197
Eur Heart J. 2007 Jun;28(12):1462-536
pubmed: 17562668
Lancet. 1997 Mar 8;349(9053):662-3
pubmed: 9078192
J Am Coll Cardiol. 2003 Sep 3;42(5):831-8
pubmed: 12957428
Int J Environ Res Public Health. 2022 Aug 09;19(16):
pubmed: 36011445
Front Cardiovasc Med. 2023 Mar 13;10:1129159
pubmed: 36993994
Trends Cardiovasc Med. 2023 Feb;33(2):125-130
pubmed: 34737088
Eur Heart J. 2020 Jan 14;41(3):407-477
pubmed: 31504439
Am J Cardiol. 2007 Mar 1;99(5):707-10
pubmed: 17317377
JAMA. 2003 Sep 24;290(12):1600-7
pubmed: 14506119
Eur Heart J Cardiovasc Imaging. 2023 Apr 24;24(5):e86-e88
pubmed: 36935564
Endocr Pract. 2015 Apr;21 Suppl 1:1-87
pubmed: 25869408
J Am Coll Cardiol. 2013 Mar 12;61(10):1054-65
pubmed: 23473411
Eur Heart J Cardiovasc Imaging. 2021 Feb 23;:
pubmed: 33619524
Atherosclerosis. 2008 Mar;197(1):415-9
pubmed: 17681507
Clin Res Cardiol. 2015 Sep;104(9):764-72
pubmed: 25791914
Circulation. 1996 Apr 15;93(8):1520-6
pubmed: 8608620
J Am Coll Cardiol. 2003 Sep 17;42(6):1084-90
pubmed: 13678935
J Am Coll Cardiol. 2001 May;37(6):1558-64
pubmed: 11345365
Circulation. 2017 Jun 13;135(24):2320-2332
pubmed: 28389572
Cardiol Clin. 1992 Nov;10(4):705-17
pubmed: 1423382
Eur Heart J. 2021 Oct 1;42(37):3869-3878
pubmed: 34449837
Eur Heart J Qual Care Clin Outcomes. 2016 Jul 01;2(3):201-207
pubmed: 29474611
JAMA. 2000 Sep 20;284(11):1392-8
pubmed: 10989401